ストックスクリーナーアプリを入手
151.17
2.77%
4.07
Gilead Sciences Inc (GILD) 最新ニュース
RBC raises target for Gilead Sciences stock to USD 126.00 - AD HOC NEWS
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings - Zacks Investment Research
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD) - Yahoo! Finance Canada
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD) - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
Cantor Fitzgerald Reaffirms Overweight Rating for Gilead Sciences (NASDAQ:GILD) - MarketBeat
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD) - TradingView
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Gilead Sciences (NASDAQ:GILD) Stock Gets Price Target Boost from JPMorgan Chase & Co. - MarketBeat
U.S. Stocks Slip Ahead of Fed Minutes; Gilead Sciences (GILD) Ga - GuruFocus
Gilead Sciences (NASDAQ:GILD) Stock Price Target Cut by Morgan Stanley - MarketBeat
Gilead Sciences Is Maintained at Overweight by Morgan Stanley - Moomoo
Gilead Sciences stock gains 2.57 percent after AI agreement expands - AD HOC NEWS
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX) - Benzinga
JPMorgan Adjusts Price Target on Gilead Sciences to $170 From $160 - marketscreener.com
Gilead Sciences signs five-year DevOps agreement with Cognizant - Pharmaceutical Technology
Gilead Sciences signs five-year DevOps agreement with Cognizant - Yahoo Finance
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences - PR Newswire
Drugmaker Gilead gets AI support for selected tech programs under a five-year extension - Stock Titan
12,110 Gilead Sciences, Inc. $GILD Shares Sold by CapWealth Advisors LLC - MarketBeat
Gilead Sciences (NASDAQ:GILD) Offers Dividend Investors Quality Income and Valuation Support - ChartMill
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know - Zacks Investment Research
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Under a prearranged trading plan, Gilead Sciences (GILD) CEO sells 15,000 shares. - Stock Titan
Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch
Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD - MarketBeat
More Upside Awaits for Gilead Sciences Stock. Stay Invested. - Barron's
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Zacks Investment Research
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Yahoo Finance
Gilead Sciences stock reports growth at EUR 133.42, plus 0.02 percent - AD HOC NEWS
Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings - kalkine.ca
Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? - finance.yahoo.com
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - finance.yahoo.com
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? - Yahoo Finance
CEUX:GISd Dividend: Does Gilead Sciences Inc Pay a Dividend? - GuruFocus
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - finance.yahoo.com
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? - Yahoo Finance
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts - MarketBeat
Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc. - MarketBeat
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Gilead Sciences stock slips 0.85 percent ahead of the open - AD HOC NEWS
Gilead: HIV Growth Is Not Enough At The Current Price (NASDAQ:GILD) - Seeking Alpha
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool
Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know - Yahoo Finance
1.20%
0.77%
大文字化:
|
ボリューム (24 時間):